NCT05012267 (OmeLEtte) is a NA clinical trial of 16-hour PP in Ards, sponsored by Ignacio Saez de la Fuente.

Who is sponsoring NCT05012267?

NCT05012267 is sponsored by Ignacio Saez de la Fuente.

What drugs are being tested in NCT05012267?

Interventions in NCT05012267: 16-hour PP.

Is NCT05012267 still recruiting?

NCT05012267 is currently completed. Last updated 28 October 2021.

Last reviewed 2021-10-28 · How we verify

NCT05012267: OmeLEtte

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).

Completed NA Last updated 28 October 2021

What this trial tests

NA trial testing 16-hour PP in Ards in 61 participants. Completed in 27 October 2021.

Timeline

25 March 2021

Primary endpoint
27 October 2021

27 October 2021

Quick facts

Lead sponsor	Ignacio Saez de la Fuente
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	61
Start date	25 March 2021
Primary completion	27 October 2021
Estimated completion	27 October 2021
Sites	1 location across Spain

Drugs / interventions tested

16-hour PP

Conditions studied

Ards — all drugs for Ards →

Sponsor

Ignacio Saez de la Fuente

Who can join

18 and older, any sex, with Ards. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The OMELETTE study is a randomised, controlled, unicentric, open-label study to prove the noninferiority of reduced prone position (PP) sessions (more tan 16 hours) versus prolonged PP (48 hours).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

ESICM LIVES 2022: part 1.
· 2022 · cited 4× · PMID 36258101 · DOI 10.1186/s40635-022-00468-1
Optimal Prone Position Duration in Patients With ARDS Due to COVID-19: The Omelette Pilot Trial.
Sáez de la Fuente I, Marcos Morales A, Muñoz Calahorro R, Álvaro Valiente E, et al · · 2024 · cited 3× · PMID 38531637 · DOI 10.4187/respcare.11192

Verify or expand the search:

Other recruiting trials for Ards

Currently open trials in the same condition.

NCT07100860 — The Effect of Single Lung Ventilation Duration on Postoperative Pulmonary Complications in Thoracic Surgery · recruiting
NCT06513299 — Effectiveness of Low Volume and Low Pressure in Severe Hypoxemic Patients · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05012267 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ignacio Saez de la Fuente
Last refreshed: 28 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05012267.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing